NO20061872L - Disulfid, sulfid, sulfoksid, og sulfoderivater av sykliske sukkere og anvendelse derav - Google Patents

Disulfid, sulfid, sulfoksid, og sulfoderivater av sykliske sukkere og anvendelse derav

Info

Publication number
NO20061872L
NO20061872L NO20061872A NO20061872A NO20061872L NO 20061872 L NO20061872 L NO 20061872L NO 20061872 A NO20061872 A NO 20061872A NO 20061872 A NO20061872 A NO 20061872A NO 20061872 L NO20061872 L NO 20061872L
Authority
NO
Norway
Prior art keywords
disulfide
sulfoxide
sulfide
cyclic sugars
sulfo derivatives
Prior art date
Application number
NO20061872A
Other languages
English (en)
Inventor
Jose Repolles Moliner
Eduardo Salas Perez-Rasilla
Francisco Pubill Coy
Original Assignee
Lacer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lacer Sa filed Critical Lacer Sa
Publication of NO20061872L publication Critical patent/NO20061872L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse beskriver nye derivater av dianhydroheksittmononitrat tilsvarende formel (I), tautomerer, farmasøytisk aksepterbare salter, promedikamenter og solvater derav, så vel som farmasøytiske preparater som omfatter disse forbindelsene og anvendelser derav.
NO20061872A 2003-10-03 2006-04-27 Disulfid, sulfid, sulfoksid, og sulfoderivater av sykliske sukkere og anvendelse derav NO20061872L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200302368A ES2258365B1 (es) 2003-10-03 2003-10-03 Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.
PCT/EP2004/010882 WO2005037842A1 (en) 2003-10-03 2004-09-29 Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof

Publications (1)

Publication Number Publication Date
NO20061872L true NO20061872L (no) 2006-06-30

Family

ID=34451643

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061872A NO20061872L (no) 2003-10-03 2006-04-27 Disulfid, sulfid, sulfoksid, og sulfoderivater av sykliske sukkere og anvendelse derav

Country Status (34)

Country Link
US (3) US7521571B2 (no)
EP (1) EP1668017B1 (no)
JP (2) JP4809769B2 (no)
KR (1) KR101141683B1 (no)
CN (1) CN1863805B (no)
AP (1) AP1976A (no)
AR (1) AR045962A1 (no)
AT (1) ATE423781T1 (no)
AU (1) AU2004281916B2 (no)
BR (1) BRPI0415020A (no)
CA (1) CA2540500C (no)
DE (2) DE602004019666D1 (no)
DK (1) DK1668017T3 (no)
EA (1) EA008942B1 (no)
EC (1) ECSP066542A (no)
ES (2) ES2258365B1 (no)
GB (1) GB2421241B (no)
GE (1) GEP20084490B (no)
GT (1) GT200400200A (no)
HR (1) HRP20090152T3 (no)
IL (1) IL174371A0 (no)
IS (1) IS8436A (no)
MX (1) MXPA06003610A (no)
NO (1) NO20061872L (no)
NZ (1) NZ546043A (no)
PA (1) PA8614201A1 (no)
PE (1) PE20050436A1 (no)
PL (1) PL1668017T3 (no)
PT (1) PT1668017E (no)
RS (1) RS20060241A (no)
SI (1) SI1668017T1 (no)
UY (1) UY28547A1 (no)
WO (1) WO2005037842A1 (no)
ZA (1) ZA200603475B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2258365B1 (es) 2003-10-03 2007-12-01 Lacer, S.A. Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.
EP1941876A1 (en) * 2006-12-28 2008-07-09 Lacer, S.A. Isosorbide mononitrate derivatives for the treatment of Inflammation and ocular hypertension
ES2332565B1 (es) * 2007-01-23 2010-10-21 Lacer, S.A. Uso de derivados de mononitrato de dianhidrohexita como agentes antiinflamatorios.
US20080193530A1 (en) * 2007-02-13 2008-08-14 Brent Blackburn Use of ranolazine for the treatment of non-coronary microvascular diseases
CA2678515A1 (en) * 2007-02-13 2008-08-21 Cv Therapeutics, Inc. Use of ranolazine for the treatment of cardiovascular diseases
US20090111826A1 (en) * 2007-02-13 2009-04-30 Louis Lange Use of ranolazine for the treatment of cardiovascular diseases
CA2678319A1 (en) * 2007-02-13 2008-08-21 Cv Therapeutics, Inc. Use of ranolazine for the treatment of coronary microvascular diseases
WO2008116083A1 (en) * 2007-03-22 2008-09-25 Cv Therapeutics, Inc. Use of ranolazine for elevated brain-type natriuretic peptide
ES2402675T3 (es) * 2007-05-31 2013-05-07 Gilead Palo Alto, Inc. Ranolazina para el péptido natriurético de tipo cerebral a niveles elevados
IE20070934A1 (en) 2007-12-21 2009-06-24 Trinity College Dublin Efficient aspirin prodrugs
US8003811B2 (en) * 2008-02-07 2011-08-23 Nicox S.A. Nitric oxide donor compounds
EP2149576A1 (en) * 2008-07-22 2010-02-03 Lacer, S.A. Isosorbide Nitrates having vasodilating activity
EP2149577B1 (en) * 2008-07-22 2011-04-27 Lacer, S.A. New stereospecific method for the preparation of dioxa-bicyclooctane compounds
EP2177216A1 (en) * 2008-10-13 2010-04-21 Lacer, S.A. Use of dianhydrohexite mononitrate derivatives as healing agents
WO2010055138A1 (en) * 2008-11-14 2010-05-20 Lacer, S.A. New stereospecific method for the preparation of dioxa-bicyclooctane compounds
EP2199294A1 (en) * 2008-12-19 2010-06-23 Lacer, S.A. New stereospecific method for the preparation of dioxa bicyclooctane nitrate compounds
ES2587191T3 (es) * 2009-12-23 2016-10-21 Arca Biopharma, Inc. Métodos y composiciones para enfermedades y afecciones cardiovasculares
FR2977252B1 (fr) * 2011-06-30 2013-08-02 Seppic Sa Nouveaux esters de derives n-acyles d'acides amines et d'isosorbide, procede pour leur preparation, et utilisation en cosmetique et comme medicament.
KR101907050B1 (ko) 2011-12-16 2018-10-11 쓰리엠 이노베이티브 프로퍼티즈 컴파니 머캅토-함유 비스안하이드로헥시톨 유도체 및 이의 용도
RU2015139514A (ru) * 2013-03-05 2017-04-07 Арчер Дэниелс Мидлэнд Компани Монотрифлаты изогексида и способ их синтеза
CN116173012A (zh) * 2022-12-05 2023-05-30 温州医科大学 白当归脑在制备缺血性脑卒中神经保护用药物中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU465217B2 (en) * 1971-04-29 1975-09-18 American Home Products Corporation Mononitrte esters of 1,4:3, 6-dianhydro-d-glucitol
US3886186A (en) 1971-04-29 1975-05-27 American Home Prod Mononitrate esters of 1,4:3,6-dianhydro-d-glucitol
DE3102947A1 (de) 1981-01-29 1982-09-02 Heinrich Mack Nachf., 7918 Illertissen Verfahren zur herstellung von isosorbid-5-nitrat
IT1204571B (it) * 1987-05-08 1989-03-10 Chiesi Farma Spa Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato,loro procedimento di preparazione e loro composizioni farmaceutiche
US4891373A (en) * 1988-11-23 1990-01-02 Pfizer Inc. Aminopropanol derivatives of 1,4:3,6-dianhydrohexitol nitrates, processes for their preparation and their use as medicaments
FR2680173A1 (fr) * 1991-08-07 1993-02-12 Hoechst Lab Nitrates organiques, leurs procedes de preparation et leur utilisation dans le traitement de maladies cardiovasculaires .
WO1994003421A2 (en) * 1992-07-30 1994-02-17 Cal International Limited Esters and combinations of an organic nitrate and a salicylate
DE4410997A1 (de) * 1994-03-30 1995-10-26 Isis Pharma Gmbh Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktionen
IL120531A (en) * 1997-03-26 2006-12-31 Yissum Res Dev Co Nitric oxide donors and pharmaceutical compositions containing them
ES2142773B1 (es) * 1998-10-07 2001-01-01 Lacer Sa Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
US20020013483A1 (en) * 2000-07-13 2002-01-31 Consortium Fur Elektrochemische Industrie Gmbh Process for the preparation of dianhydrohexitol bisacylates
EP1337283A4 (en) * 2000-10-27 2005-05-18 Nitromed Inc METHOD FOR THE TREATMENT OF VASCULAR DISORDERS MARKED BY STICK OXIDE DEFICIENCY
UA63467A (en) 2003-04-22 2004-01-15 Pharmaceutical composition of organic nitrates, dosage form based on pharmaceutical composition of organic nitrates and method of manufacture
ES2258365B1 (es) * 2003-10-03 2007-12-01 Lacer, S.A. Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.

Also Published As

Publication number Publication date
ES2322468T3 (es) 2009-06-22
DE112004001860T5 (de) 2006-07-27
MXPA06003610A (es) 2006-06-05
WO2005037842A1 (en) 2005-04-28
US7777058B2 (en) 2010-08-17
AR045962A1 (es) 2005-11-16
AU2004281916A1 (en) 2005-04-28
JP2011012081A (ja) 2011-01-20
PL1668017T3 (pl) 2009-07-31
NZ546043A (en) 2009-02-28
BRPI0415020A (pt) 2006-11-07
PE20050436A1 (es) 2005-06-23
AP1976A (en) 2009-03-16
KR20060066743A (ko) 2006-06-16
DK1668017T3 (da) 2009-05-11
GB2421241B (en) 2008-04-16
UY28547A1 (es) 2005-04-29
EP1668017B1 (en) 2009-02-25
CN1863805A (zh) 2006-11-15
ATE423781T1 (de) 2009-03-15
US7521571B2 (en) 2009-04-21
SI1668017T1 (sl) 2009-08-31
CN1863805B (zh) 2010-06-16
US20090169560A1 (en) 2009-07-02
IL174371A0 (en) 2006-08-01
EA200600694A1 (ru) 2006-10-27
EP1668017A1 (en) 2006-06-14
HK1092807A1 (en) 2007-02-16
GB2421241A (en) 2006-06-21
AP2006003605A0 (en) 2006-04-30
EA008942B1 (ru) 2007-10-26
DE602004019666D1 (de) 2009-04-09
US8541607B2 (en) 2013-09-24
JP4809769B2 (ja) 2011-11-09
ECSP066542A (es) 2006-10-17
CA2540500A1 (en) 2005-04-28
GB0605574D0 (en) 2006-04-26
ES2258365B1 (es) 2007-12-01
ZA200603475B (en) 2007-09-26
HRP20090152T3 (en) 2009-05-31
US20100196387A1 (en) 2010-08-05
KR101141683B1 (ko) 2012-05-07
ES2258365A1 (es) 2006-08-16
JP2007507451A (ja) 2007-03-29
IS8436A (is) 2006-05-03
GEP20084490B (en) 2008-09-25
GT200400200A (es) 2005-05-23
AU2004281916B2 (en) 2010-10-21
RS20060241A (sr) 2008-06-05
PT1668017E (pt) 2009-03-09
CA2540500C (en) 2012-08-28
PA8614201A1 (es) 2005-05-24
US20060235052A1 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
NO20061872L (no) Disulfid, sulfid, sulfoksid, og sulfoderivater av sykliske sukkere og anvendelse derav
NO20080789L (no) 1,4-benzotiazepin 1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende denne forbindelsen og anvendelse derav som et hypolipid
NO20052493L (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger.
NO20050828L (no) lndol-3-svovelderivater
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
NO20076648L (no) Novel thiophene derivatives
NO20076018L (no) Lagringsstabile opplosninger av optiske hvitemidler
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
NO20092286L (no) Nitrogenhaldige heterosykliske forbindelser og anvendelse derav
NO20064032L (no) DPP-IV inhibitorer
CY1111481T1 (el) Υποκατεστημενα αρυλοκυκλοπροπυλακεταμιδια ως ενεργοποιητες γλυκοκινασης
NO20076478L (no) Substituerte oksadiazolderivater som positive allosteriske modulatorer av metabotrope glutamatreseptorer
MY142018A (en) Thiophene derivatives as chk 1 inihibitors
NO20090910L (no) Sulfonamid-derivater som adrenerge agonister og muskariniske antagonister
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
NO20070089L (no) DPP-IV inhibitorer
GEP20115166B (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
NO20054787L (no) Indenderivater som farmasotiske midler
TW200800962A (en) Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
WO2005123077A3 (en) Heteroaryl sulfones and sulfonamides and therapeutic uses thereof
NO20060718L (no) Substituerte tiofoner og deres anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application